slrn

ACELYRIN, Inc. Rings the Opening Bell in Celebration of its IPO

Date & Time
Location

About This Event

ACELYRIN, Inc. (Nasdaq: SLRN), a late-stage clinical biopharma company creating an industry-leading immunology portfolio, visits the Nasdaq MarketSite in Times Square. In honor of the occasion, Shao-Lee Lin, M.D., Ph.D., Founder and Chief Executive Officer, rings the Opening Bell.

Nasdaq watch

See what's playing at Nasdaq

WATCH NOW ->